San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
With management education expanding beyond postgraduate programmes, these courses give students the option to align their ...
President Trump announced nine more companies joining TrumpRx, aiming for U.S.-Europe drug price parity using tariffs as leverage. TrumpRx will offer future drug releases at most-favored-nation ...
Review of Vatrer's compact 48V 105Ah mini lithium battery. Fits tight spaces, delivers 50-mile range, charges in 6 hours.
Cowtown is bringing pure decadence to the table this New Year’s Eve. The Mont is hosting a seven-course dinner featuring ...
Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - are ...
These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down ...
With an EV, you're unlikely to achieve the stated mileage unless you adjust your driving habits and learn the subtleties of ...
My name is Todd Tushla, I'm the Vice President of Investor Relations at Neurocrine Biosciences. And on behalf of our entire company, welcome to our 2025 R&D Day, whether you're here in person, on the ...
Dr Rahul Banerjee discusses ASH 2025 and bispecific antibodies in myeloma, including data from MajesTEC-3, IFM2021-01, and ...
For the BCIA, 2025 has been a thoroughly successful and positive year. With more than 270 apprentices on its Level 4 Building ...
From Venice to Kyoto and Costa Rica, it's going to be an unforgettable year for newcomers and familiar faces alike.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results